Douglas Lane & Associates, LLC Johnson & Johnson Transaction History

Douglas Lane & Associates, LLC

$6.79 Billion
Q1 2024

A detailed history of Douglas Lane & Associates, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 545,254 shares of JNJ stock, worth $79.6 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares

545,254

Previous 520,568 4.74%

Holding current value

$79.6 Million

Previous $81.6 Million 5.71%

% of portfolio

1.27%

Previous 1.28%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	BUY	$155.22 - $162.74 $3.83 Million - $4.02 Million	24,686 Added 4.74%	545,254 $86.3 Million
Q4 2023 Jan 17, 2024	BUY	$145.6 - $158.88 $5.88 Million - $6.41 Million	40,363 Added 8.41%	520,568 $81.6 Million
Q3 2023 Oct 16, 2023	BUY	$155.75 - $174.48 $5.2 Million - $5.83 Million	33,412 Added 7.48%	480,205 $74.8 Million
Q2 2023 Jul 19, 2023	BUY	$154.35 - $166.11 $5.27 Million - $5.67 Million	34,122 Added 8.27%	446,793 $74 Million
Q1 2023 Apr 17, 2023	BUY	$151.05 - $180.26 $2.44 Million - $2.92 Million	16,174 Added 4.08%	412,671 $64 Million

Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $192,400 - $215,927	-1,201 Reduced 0.3%	396,497 $70 Million
Q4 2022 Jan 17, 2023	BUY	$160.2 - $179.79 $6 Million - $6.74 Million	37,478 Added 10.4%	397,698 $70.3 Million
Q3 2022 Oct 14, 2022	BUY	$161.33 - $179.52 $543,520 - $604,802	3,369 Added 0.94%	360,220 $58.8 Million
Q2 2022 Jul 18, 2022	BUY	$168.19 - $186.01 $1.28 Million - $1.42 Million	7,638 Added 2.19%	356,851 $63.3 Million
Q1 2022 Apr 25, 2022	BUY	$158.14 - $179.59 $5.88 Million - $6.68 Million	37,212 Added 11.93%	349,213 $61.9 Million
Q4 2021 Jan 25, 2022	BUY	$155.93 - $173.01 $7.55 Million - $8.38 Million	48,438 Added 18.38%	312,001 $53.4 Million
Q3 2021 Oct 21, 2021	BUY	$161.5 - $179.47 $3.8 Million - $4.23 Million	23,548 Added 9.81%	263,563 $42.6 Million
Q2 2021 Jul 19, 2021	BUY	$159.48 - $171.07 $3.47 Million - $3.72 Million	21,764 Added 9.97%	240,015 $39.5 Million
Q1 2021 Apr 19, 2021	BUY	$153.07 - $170.48 $3.56 Million - $3.96 Million	23,243 Added 11.92%	218,251 $35.9 Million
Q4 2020 Jan 14, 2021	BUY	$137.11 - $157.38 $5.46 Million - $6.27 Million	39,822 Added 25.66%	195,008 $30.7 Million
Q3 2020 Oct 19, 2020	BUY	$140.38 - $153.83 $1.12 Million - $1.23 Million	7,966 Added 5.41%	155,186 $23.1 Million
Q2 2020 Jul 28, 2020	BUY	$128.81 - $155.51 $2.95 Million - $3.56 Million	22,898 Added 18.42%	147,220 $20.7 Million
Q1 2020 Apr 20, 2020	BUY	$111.14 - $153.99 $6.52 Million - $9.04 Million	58,700 Added 89.45%	124,322 $16.3 Million
Q4 2019 Jan 27, 2020	BUY	$127.5 - $146.44 $142,417 - $163,573	1,117 Added 1.73%	65,622 $9.57 Million
Q3 2019 Oct 16, 2019	BUY	$126.95 - $142.14 $51,668 - $57,850	407 Added 0.63%	64,505 $8.35 Million
Q2 2019 Jul 08, 2019	SELL	$131.15 - $144.24 $207,348 - $228,043	-1,581 Reduced 2.41%	64,098 $8.93 Million
Q1 2019 Apr 23, 2019	BUY	$125.72 - $139.79 $50,916 - $56,614	405 Added 0.62%	65,679 $9.18 Million
Q4 2018 Jan 17, 2019	SELL	$122.84 - $147.84 $358,815 - $431,840	-2,921 Reduced 4.28%	65,274 $8.42 Million
Q3 2018 Oct 09, 2018	SELL	$121.58 - $142.88 $67,841 - $79,727	-558 Reduced 0.81%	68,195 $9.42 Million
Q2 2018 Jul 23, 2018	SELL	$119.4 - $131.76 $221,248 - $244,151	-1,853 Reduced 2.62%	68,753 $8.34 Million
Q1 2018 Apr 23, 2018	SELL	$125.1 - $148.14 $338,895 - $401,311	-2,709 Reduced 3.7%	70,606 $9.05 Million
Q4 2017 Jan 24, 2018	SELL	$131.22 - $143.62 $959,874 - $1.05 Million	-7,315 Reduced 9.07%	73,315 $10.2 Million
Q3 2017 Oct 19, 2017	BUY	$129.47 - $135.38 $10.4 Million - $10.9 Million	80,630	80,630 $10.5 Million

Others Institutions Holding JNJ

# of Institutions

4,146

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $382B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.

Account

Douglas Lane & Associates, LLC Johnson & Johnson Transaction History